ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 49 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $125,000 | +28.9% | 17,743 | 0.0% | 0.00% | – |
| Q4 2018 | $97,000 | -49.2% | 17,743 | 0.0% | 0.00% | – |
| Q3 2018 | $191,000 | -17.3% | 17,743 | 0.0% | 0.00% | – |
| Q2 2018 | $231,000 | +145.7% | 17,743 | +108.9% | 0.00% | – |
| Q1 2018 | $94,000 | +10.6% | 8,495 | 0.0% | 0.00% | – |
| Q4 2017 | $85,000 | – | 8,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $24,309,000 | 36.46% |
| Pharmstandard International S.A. | 873,031 | $9,376,000 | 32.28% |
| TRV GP II, LLC | 2,790,964 | $29,975,000 | 17.60% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $35,768,000 | 6.55% |
| Partner Investment Management, L.P. | 301,889 | $3,242,000 | 2.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 295,199 | $3,170,000 | 0.36% |
| PFM Health Sciences, LP | 1,768,568 | $18,994,000 | 0.28% |
| Perceptive Advisors | 250,000 | $2,685,000 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 4,616 | $200,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $894,000 | 0.01% |